Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

BACKGROUND: In the treatment for glioblastoma (GBM), treatment modalities, such as bevacizumab (BEV) and carmustine wafers implants have been approved in Japan since 2013. However, it is unclear whether such a trend in treatment complexity can accelerate treatment centralization. The aim of this stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Oncol
Autors principals: Funakoshi, Yusuke, Hata, Nobuhiro, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Takigawa, Kosuke, Yoshimoto, Koji, Mizoguchi, Masahiro, Iihara, Koji
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286941/
https://ncbi.nlm.nih.gov/pubmed/33974184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-021-01929-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars